David Jones, Managing Director of Chrysalis Ventures, primarily invests in early-stage and expansion-stage. See sector focus and contact routes.
David Jones, Managing Director of Chrysalis Ventures, primarily invests in early-stage and expansion-stage technology-enabled companies in healthcare, education, fintech, and business services, typically deploying $1 million to $10 million per deal. His distinctive thesis centers on partnering with proven operators in Mid-America and the South to foster growth in markets underserved by technology, with a recent strategic focus on innovation in end-of-life care. Notable portfolio companies include Appriss (sold to Bain Capital), AlayaCare (end-of-life care software), Sanovia ($8M raise), and My Health Direct ($4M Series A).
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Louisville.
Investors like David Jones · Full investor directory · Investor access · Company funding database
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide